LeonaBio (LONA) Invested Capital (2022 - 2024)

LeonaBio (LONA) has 3 years of Invested Capital data on file, last reported at $10.0 million in Q3 2024.

• On a quarterly basis, Invested Capital changed 0.0% year-over-year to $10.0 million in Q3 2024; TTM through Jun 2025 was $10.0 million, a 75.0% decrease from a year earlier, with the FY2023 full-year figure at $10.0 million, changed 0.0% from the prior year.
• Invested Capital for Q3 2024 stood at $10.0 million, roughly flat from $10.0 million in the prior quarter.
• Over the last five years, Invested Capital for LONA reached as high as $10.0 million in Q4 2022 and fell as low as $10.0 million in Q4 2022.
• Historically, Invested Capital has averaged $10.0 million across 3 years, with a median of $10.0 million in 2022.
• On a YoY basis, Invested Capital climbed as much as 0.0% in 2023 and fell as far as 0.0% in 2023.
• Year by year, Invested Capital stood at $10.0 million in 2022, then changed by 0.0% to $10.0 million in 2023, then changed by 0.0% to $10.0 million in 2024.
• Per Business Quant data, the three most recent Invested Capital figures were $10.0 million in Q3 2024, $10.0 million in Q2 2024, and $10.0 million in Q1 2024.